Reid Hoffman的新创办人Manas AI旨在以24.6M美元的资金加速对激进性癌症的药物发现。 Reid Hoffman's new startup, Manas AI, aims to accelerate drug discovery for aggressive cancers with $24.6M funding.

Reid Hoffman是LinkedIn公司的共同创始人,他发起了Manas AI,这是一个使用AI的启动项目,目的是加速发现前列腺癌、淋巴瘤和三重阴性乳腺癌等具有攻击性的癌症的药物。 Reid Hoffman, co-founder of LinkedIn, has launched Manas AI, a startup using AI to speed up drug discovery for aggressive cancers like prostate cancer, lymphoma, and triple-negative breast cancer. 该公司筹集了2 460万美元的种子资金,与微软公司合作利用Azure云计算。 The company has raised $24.6 million in seed funding and partnered with Microsoft to leverage Azure cloud-computing. 为了减少药物开发的漫长而昂贵的过程,Manas AI设法更快地将新的治疗方法投放市场。 With the aim of reducing the lengthy and costly process of drug development, Manas AI seeks to bring new treatments to market faster.